Mostrar el registro sencillo del ítem

Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

dc.contributor.authorJohnson, Catherine Owensspa
dc.contributor.authorNguyen, Minhspa
dc.contributor.authorRoth, Gregory Aspa
dc.contributor.authorNichols, Emmaspa
dc.contributor.authorAlam, Tahiyaspa
dc.contributor.authorAbate, Deguspa
dc.contributor.authorAbd-Allah, Foadspa
dc.contributor.authorAbdelalim, Ahmedspa
dc.contributor.authorAbraha, Haftom Nigusespa
dc.contributor.authorAbu-Rmeileh, Niveen MEspa
dc.contributor.authorAlvis-Guzman, Nelsonspa
dc.date.accessioned2019-06-04T19:32:14Z
dc.date.available2019-06-04T19:32:14Z
dc.date.issued2019
dc.identifier.urihttp://hdl.handle.net/11323/4784spa
dc.description.abstractBackground Stroke is a leading cause of mortality and disability worldwide and the economic costs of treatment and post-stroke care are substantial. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic, comparable method of quantifying health loss by disease, age, sex, year, and location to provide information to health systems and policy makers on more than 300 causes of disease and injury, including stroke. The results presented here are the estimates of burden due to overall stroke and ischaemic and haemorrhagic stroke from GBD 2016.spa
dc.description.abstractAntecedentes El accidente cerebrovascular es una de las principales causas de mortalidad y discapacidad en todo el mundo y los costos económicos del tratamiento y la atención posterior al accidente cerebrovascular son considerables. El Estudio de la Carga Global de Enfermedades, Lesiones y Factores de Riesgo (GBD, por sus siglas en inglés) proporciona un método sistemático y comparable para cuantificar la pérdida de salud por enfermedad, edad, sexo, año y ubicación para brindar información a los sistemas de salud y a los responsables políticos sobre más de 300 causas. de enfermedades y lesiones, incluyendo apoplejía. Los resultados que se presentan aquí son las estimaciones de la carga debida al accidente cerebrovascular general y al accidente cerebrovascular isquémico y hemorrágico de GBD 2016.spa
dc.language.isoeng
dc.publisherThe Lancetspa
dc.relation.ispartofDOI:https://doi.org/10.1016/S1474-4422(19)30034-1spa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.subjectAccidente cerebrovascularspa
dc.subjectMortalidad y discapacidadspa
dc.subjectCarga Global de Enfermedadesspa
dc.subjectMétodo sistemáticospa
dc.subjectStrokespa
dc.subjectMortality and disabilityspa
dc.subjectGlobal Disease Burdenspa
dc.subjectSystematic methodspa
dc.titleGlobal, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016spa
dc.typeArtículo de revistaspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.identifier.instnameCorporación Universidad de la Costaspa
dc.identifier.reponameREDICUC - Repositorio CUCspa
dc.identifier.repourlhttps://repositorio.cuc.edu.co/spa
dc.relation.references1 Rajsic S, Gothe H, Borba HH, et al. Economic burden of stroke: a systematic review on post-stroke care. Eur J Health Econ 2018; published online June 16. DOI:10.1007/s10198–018–0984–0.spa
dc.relation.references2 GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol 2017; 16: 877–97.spa
dc.relation.references3 Yan LL, Li C, Chen J, et al. Stroke. In: Prabhakaran D, Anand S, Gaziano TA, et al, eds. Cardiovascular, respiratory, and related disorders, 3rd edn. Washington, DC: The International Bank for Reconstruction and Development/The World Bank, 2017. http://www. ncbi.nlm.nih.gov/books/NBK525145/ (accessed Nov 9, 2018).spa
dc.relation.references4 Venketasubramanian N, Yoon BW, Pandian J, Navarro JC. Stroke epidemiology in South, East, and South-East Asia: a review. J Stroke 2017; 19: 286–94.spa
dc.relation.references5 Thrift AG, Thayabaranathan T, Howard G, et al. Global stroke statistics. Int J Stroke 2017; 12: 13–32.spa
dc.relation.references6 Arnao V, Acciarresi M, Cittadini E, Caso V. Stroke incidence, prevalence and mortality in women worldwide. Int J Stroke 2016; 11: 287–301.spa
dc.relation.references7 GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390: 1151–210.spa
dc.relation.references8 GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390: 1211–59.spa
dc.relation.references9 Stevens GA, Alkema L, Black RE, et al. Guidelines for accurate and transparent health estimates reporting: the GATHER statement. Lancet 2016; 388: e19–23.spa
dc.relation.references10 Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ 1980; 58: 113–30.spa
dc.relation.references11 Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009; 8: 355–69.spa
dc.relation.references12 GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390: 1345–422.spa
dc.relation.references13 O’Donnell MJ, Chin SL, Rangarajan S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet 2016; 388: 761–75.spa
dc.relation.references14 Feigin VL, Norrving B, George MG, Foltz JL, Roth GA, Mensah GA. Prevention of stroke: a strategic global imperative. Nat Rev Neurol 2016; 12: 501–12.spa
dc.relation.references15 Emberson J, Whincup P, Morris R, Walker M, Ebrahim S. Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease. Eur Heart J 2004; 25: 484–91.spa
dc.relation.references16 Krogsbøll LT, Jørgensen KJ, Grønhøj Larsen C, Gøtzsche PC. General health checks in adults for reducing morbidity and mortality from disease: Cochrane systematic review and meta-analysis. BMJ 2012; 345: e7191.spa
dc.relation.references17 Jørgensen T, Jacobsen RK, Toft U, Aadahl M, Glümer C, Pisinger C. Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ 2014; 348: g3617.spa
dc.relation.references18 Krishnamurthi R, Hale L, Barker-Collo S, et al. Mobile technology for primary stroke prevention: a proof-of-concept pilot randomised controlled trial. Stroke 2018; 50: 196–98.spa
dc.relation.references19 Krishnamurthi R, Bhattaacharjee R, Parmar P. Effectiveness of the stroke riskometer app for primary stroke prevention: a pilot RCT. International Stroke Conference; Los Angeles; Jan 23–26, 2018. 85.spa
dc.relation.references20 Gaciong Z, Siński M, Lewandowski J. Blood pressure control and primary prevention of stroke: summary of the recent clinical trial data and meta-analyses. Curr Hypertens Rep 2013; 15: 559–74.spa
dc.relation.references21 Heller DJ, Coxson PG, Penko J, et al. Evaluating the impact and cost-effectiveness of statin use guidelines for primary prevention of coronary heart disease and stroke. Circulation 2017; 136: 1087–98.spa
dc.relation.references22 Wang W, Zhang B. Statins for the prevention of stroke: a meta-analysis of randomized controlled trials. PLoS One 2014; 9: e92388.spa
dc.relation.references23 Gaziano TA, Opie LH, Weinstein MC. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet 2006; 368: 679–86.spa
dc.relation.references24 Brainin M, Feigin V, Martins S, et al. Cut stroke in half: polypill for primary prevention in stroke. Int J Stroke 2018; 13: 633–47.spa
dc.relation.references25 Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals From the American Heart Association/American Stroke Association. Stroke 2018; 49: e46–110.spa
dc.relation.references25 Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals From the American Heart Association/American Stroke Association. Stroke 2018; 49: e46–110.spa
dc.relation.references26 Smith WS, Furlan AJ. Brief history of endovascular acute ischemic stroke treatment. Stroke 2016; 47: e23–26.spa
dc.relation.references27 Owolabi M, Johnson W, Khan T, Feigin V. Effectively combating stroke in low- and middle-income countries: placing proof in pragmatism—The Lancet Neurology Commission. J Stroke Med 2018; 1: 65–67.spa
dc.relation.references28 Huisman MV, Lip GY, Diener HC, et al. Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation. Am Heart J 2014; 167: 329–34.spa
dc.relation.references29 Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857–67.spa
dc.relation.references30 Psaty BM, Delaney JA, Arnold AM, et al. Study of cardiovascular health outcomes in the era of claims data: the cardiovascular health study. Circulation 2016; 133: 156–64.spa
dc.relation.references31 Kottke TE, Baechler CJ, Parker ED. Accuracy of heart disease prevalence estimated from claims data compared with an electronic health record. Prev Chronic Dis 2012; 9: E141.spa
dc.relation.references32 Jensen ET, Cook SF, Allen JK, et al. Enrollment factors and bias of disease prevalence estimates in administrative claims data. Ann Epidemiol 2015; 25: 519–525.e2.spa
dc.relation.references33 Coull AJ, Lovett JK, Rothwell PM. Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ 2004; 328: 326.spa
dc.relation.references34 Feigin V, Norrving B, Sudlow CLM, Sacco RL. Updated criteria for population-based stroke and transient ischemic attack incidence studies for the 21st century. Stroke 2018; 49: 2248–55.spa
dc.relation.references35 WHO. Global action plan for the prevention and control of NCDs 2013–2020. Geneva: World Health Organization. http://www.who. int/nmh/events/ncd_action_plan/en/ (accessed Oct 26, 2018).spa
dc.title.translatedCarga mundial, regional y nacional de ictus, 1990-2016: Un análisis sistemático de la carga global de la enfermedad. Estudio 2016spa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.redcolhttp://purl.org/redcol/resource_type/ARTspa
dc.type.versioninfo:eu-repo/semantics/acceptedVersionspa
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aaspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa


Ficheros en el ítem

Thumbnail
Nombre:
regional, and national burden ...
Tamaño:
1.366Mb
Formato:
PDF
Ver/
Thumbnail
Nombre:
license_rdf
Tamaño:
1.006Kb
Formato:
application/rdf+xml
Ver/

Este ítem aparece en la(s) siguiente(s) colección(ones)

  • Artículos científicos [3154]
    Artículos de investigación publicados por miembros de la comunidad universitaria.

Mostrar el registro sencillo del ítem

http://creativecommons.org/licenses/by-nc-sa/4.0/
Excepto si se señala otra cosa, la licencia del ítem se describe como http://creativecommons.org/licenses/by-nc-sa/4.0/